Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Grants (Details)

v3.22.1
Stock-Based Compensation - Grants (Details)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Common Class A  
Number of options  
Outstanding at beginning of period | shares 42,110
Exercised | shares (56)
Forfeited/Cancelled | shares (2,936)
Outstanding at end of period | shares 39,118
Exercisable at end of period | shares 25,183
WAEP  
Outstanding at beginning of period | $ / shares $ 9.23
Exercised | $ / shares 2.80
Forfeited/Cancelled | $ / shares 11.16
Outstanding at end of period | $ / shares 9.10
Exercisable at end of period | $ / shares $ 11.19
Additional disclosures  
Weighted average remaining life - options outstanding 3 years 3 months 18 days
Weighted average remaining life - options exercisable 2 years 3 months 18 days
Aggregate intrinsic value of options outstanding | $ $ 18
Aggregate intrinsic value of options exercisable | $ $ 6
Common Class B  
Number of options  
Outstanding at beginning of period | shares 2,221
Outstanding at end of period | shares 2,221
Exercisable at end of period | shares 2,221
WAEP  
Outstanding at beginning of period | $ / shares $ 12.25
Outstanding at end of period | $ / shares 12.25
Exercisable at end of period | $ / shares $ 12.25
Additional disclosures  
Weighted average remaining life - options outstanding 1 year 6 months
Weighted average remaining life - options exercisable 1 year 6 months